Wall Street’s Top Stock Picks: Major Analyst Calls for Nvidia, Tesla, Apple, GM, and More on Monday

Wall Street analysts were busy on Monday, issuing a flurry of upgrades, downgrades, and new coverage across a diverse range of companies from technology giants to automotive innovators and niche biotech firms. Here’s a detailed look at the most impactful calls:

Piper Sandler Elevates Rivian and Mobileye to Overweight

Piper Sandler expressed strong confidence in both Rivian and Mobileye, upgrading them from neutral to overweight. The firm highlighted Rivian’s "de-risked balance sheet, a smooth R2 ramp, and an improved demand outlook" as key drivers. For Mobileye, Piper Sandler noted it is "nearing floor valuation while seizing control of its own destiny," finding both stocks compelling investment opportunities.

Piper Sandler Initiates Williams-Sonoma as Overweight

Piper Sandler commenced coverage of Williams-Sonoma with an overweight rating and a $253 price target, hailing the stock as "best-in-class." The firm praised the company for its "best-in-class EBIT margin" and "steady outperformance in a fairly depressed home furnishing industry backdrop."

JPMorgan Initiates Rhythm Pharmaceuticals Overweight

JPMorgan began coverage of Rhythm Pharmaceuticals (RYTM) with an overweight rating and a December 2027 price target of $145. Analysts believe shares of the biotech company possess significant upside potential.

Citizens Initiates Sonida Senior Living as Market Outperform

Citizens initiated coverage on Sonida Senior Living, Inc. (SNDA) with a Market Outperform rating and a $50 price target. The firm stated that "the recently scaled company has become significantly more attractive to institutional investors" and is "firing on all cylinders."

Roth Initiates Aduro Clean Technologies as Buy

Roth launched coverage of Aduro Clean Technologies (ADUR) with a Buy rating and a $30 price target. The firm sees considerable growth potential for the plastics recycling company, noting ADUR's "platform chemistry technology that upgrades materials, including waste plastic and paraffinic crude, into higher value products."

Phillip Capital Upgrades Alphabet to Buy from Accumulate

Phillip Capital upgraded Alphabet (GOOGL) to buy from accumulate, signaling a "constructive" long-term view on the stock. Despite "near-term earnings revisions," the firm remains optimistic about Google's future outlook.

JPMorgan Initiates BWX Technologies as Overweight

JPMorgan began coverage of nuclear materials company BWX Technologies (BWXT) with an Overweight rating and a December 2027 price target of $230, emphasizing the company's "wide moat."

Piper Sandler Initiates Arlo Technologies as Overweight

Piper Sandler started coverage on Arlo Technologies, a provider of connected physical security devices, with an Overweight rating and a $17 price target. The firm believes the market for Arlo's products is "underpenetrated."

JPMorgan Initiates Cadre Holdings as Overweight

JPMorgan initiated coverage of Cadre Holdings (NYSE: CDRE) with an Overweight rating and a December 2027 price target of $40, suggesting approximately 32% upside from current levels. The firm considers the safety products company to be undervalued.

UBS Upgrades Cameco to Buy from Neutral

UBS upgraded uranium company Cameco to Buy following a recent pullback in its stock price (-18% in one month & -27% in six months). UBS believes the dip was "driven by broader market and AI-related sentiment rather than any change in fundamentals."

Goldman Sachs Initiates Neutron Holdings (LIME) as Buy

Goldman Sachs commenced coverage of micromobility platform company Neutron Holdings, Inc. (LIME) with a Buy rating and a 12-month price target of $39, expressing a bullish outlook.

Goldman Sachs Initiates Bending Spoons as Buy

Goldman Sachs initiated coverage of Bending Spoons S.p.A. (BSP) with a Buy rating and a 12-month price target of $43. The firm sees significant upside, describing Bending Spoons as a "technology-based conglomerate that focuses on acquiring and transforming mature digital businesses."

Morgan Stanley Initiates Somnigroup as Overweight

Morgan Stanley began coverage of mattress manufacturer Somnigroup, assigning an Overweight rating. The firm cited the company's "competitive moat," highlighting industry consolidation, vertical integration potential for earnings growth, and a strong track record of share gains and market leadership.

Jefferies Upgrades General Motors to Buy from Hold

Jefferies upgraded General Motors (GM) to Buy from Hold, projecting robust free-cash flow. The firm's analysis from Q2 earnings indicated "confidence that 2027 will further strengthen GM's position within the US profit oligopoly and deliver $10+bn of real FCF."

Jefferies Upgrades Ford to Buy from Hold

Jefferies also upgraded Ford to Buy from Hold, suggesting the stock is at a "margin trough." The firm anticipates Q2 to be a low point for volume, with production expected to normalize and healthy US market conditions potentially leading management to raise guidance.

Wolfe Reiterates SpaceX as Outperform

Wolfe reiterated its Outperform rating on SpaceX, expressing continued bullishness on the company, particularly after the recent Starship flight test. The firm noted the successful separation of the Super Heavy booster and a controlled splashdown in the Gulf.

UBS Initiates ITG as Buy

UBS initiated coverage of marketing technology company ITG with a Buy rating and an $18 price target. The firm anticipates 40% upside, believing that "growth over the next 2-3 years from digital connectivity markets, and company-specific initiatives, is not priced in."

Bernstein Reiterates Nvidia as Outperform

Bernstein maintained its Outperform rating on Nvidia, emphasizing the "enormous" and still early datacenter opportunity with "material upside still possible."

Barclays Downgrades Anheuser-Busch InBev to Equal Weight from Overweight

Barclays downgraded Anheuser-Busch InBev (ABI) to Equal Weight, citing a combination of negative catalysts. These include Brazil's new Imposto Seletivo (Sin Tax) taking effect in January 2027, which is expected to create a "structural pricing and earnings headwind," and a "difficult 2027 comp against a World Cup-supported 2026."

Wells Fargo Initiates Helus Pharma as Overweight

Wells Fargo began coverage of psychedelics company Helus Pharma (HELP) with an Overweight rating, seeing significant upside potential.

Goldman Sachs Reiterates Apple as Buy, Raises Price Target

Goldman Sachs reiterated its Buy rating on Apple, raising its 12-month price target to $370 from $330 ahead of upcoming earnings. The firm maintains a strong conviction in the tech giant.

BMO Upgrades Robert Half to Outperform from Market Perform

BMO upgraded Robert Half (RHI) to Outperform, advising investors to "buy the dip" after the stock's recent sell-off.

Deutsche Bank Reiterates Tesla as Buy, Lowers Price Target

Deutsche Bank maintained its Buy rating on Tesla but lowered its price target to $420 from $465 per share. Following recent earnings, the bank believes "Robotaxi and especially Optimus (supply chain) are scaling slower than anticipated," which has disappointed the market.

Bank of America Initiates Clean Harbors as Buy

Bank of America initiated coverage of Clean Harbors (CLH) with a Buy rating, describing the hazardous waste management company as "compounding cash." The firm highlighted CLH as "the leading provider of hazardous waste management services in NA, operating a highly integrated, one-stop-shop platform."

Mizuho Reiterates Advanced Micro Devices (AMD) as Outperform

Mizuho reiterated its Outperform rating on Advanced Micro Devices (AMD), raising its price target to $625 from $615. The firm expressed optimism about AMD's partnership with Cerebras, which "could drive upside."

Wells Fargo Upgrades SiriusXM to Equal Weight from Underweight

Wells Fargo upgraded SiriusXM (SIRI) to Equal Weight, admitting that its prior underweight call was incorrect. The firm acknowledged missing "a meaningful market revaluation of SIRI's spectrum" despite ongoing debates about satellite radio pressures.

Citi Initiates Securitize as Buy

Citi initiated coverage of tokenization platform company Securitize (SECZ) with a Buy/High Risk rating and a $10 price target. The firm views Securitize as "the critical infrastructure for the tokenization of real-world assets," recognizing its "durable competitive moat."